Genetic ablation of LCN2 in Apoe-null mice significantly suppressed the severity of hepatic injury and inflammation, whereas chronic administration of recombinant LCN2 enhanced the severity of HFHCD-induced NASH (135). Here, APOE is linked to metabolic dysfunction-associated steatohepatitis.